Nitric Oxide Deficiency in Pulmonary Hypertension: Pathobiology and Implications for Therapy
Open Access
- 1 January 2013
- journal article
- review article
- Published by Wiley in Pulmonary Circulation
- Vol. 3 (1) , 20-30
Abstract
Nitric oxide (NO) is a diffusible gas with diverse roles in human physiology and disease. Significant progress in the understanding of its biological effects has taken place in recent years. This has led to a better understanding of the pathobiology of pulmonary hypertension (PH) and the development of new therapies. This article provides an overview of the NO physiology and its role in the pathobiology of lung diseases, particularly PH. We also discuss current and emerging specific treatments that target NO signaling pathways in PH.Keywords
Funding Information
- National Center for Research Resources
- National Institutes of Health (HL081064, HL107147, HL095181, RR026231)
- Ohio Department of Development
- American Heart Association (0826095H)
This publication has 173 references indexed in Scilit:
- Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase ActivationJournal of Biological Chemistry, 2011
- Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitriteAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJACC, 2009
- Bringing down the ROS: a new therapeutic approach for PPHNAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Inhaled NO for Preterm Infants — Getting to Yes?New England Journal of Medicine, 2006
- Inhaled Nitric Oxide for Premature Infants with Severe Respiratory FailureNew England Journal of Medicine, 2005
- Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertensionThe FASEB Journal, 2004
- Exogenous Nitric Oxide Inhibits Proliferation of Cultured Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1994
- Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generationBiochemical and Biophysical Research Communications, 1992